Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
6.20
-0.09 (-1.43%)
At close: Apr 28, 2026, 4:00 PM EDT
6.22
+0.02 (0.32%)
After-hours: Apr 28, 2026, 7:24 PM EDT
Candel Therapeutics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Candel Therapeutics stock have an average target of 19, with a low estimate of 7.00 and a high estimate of 26. The average target predicts an increase of 206.45% from the current stock price of 6.20.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 18, 2026.
Analyst Ratings
The average analyst rating for Candel Therapeutics stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $22 → $26 | Strong Buy | Maintains | $22 → $26 | +319.35% | Mar 18, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $24 → $22 | Strong Buy | Maintains | $24 → $22 | +254.84% | Mar 13, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +303.23% | Mar 13, 2026 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $15 | Buy | Reiterates | $15 | +141.94% | Dec 8, 2025 |
| Freedom Broker | Freedom Broker | Strong Buy Maintains $13 → $14 | Strong Buy | Maintains | $13 → $14 | +125.81% | Nov 21, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
57.57M
EPS This Year
-1.32
from -0.72
EPS Next Year
-0.65
from -1.32
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | 138.9M | ||||||
| Avg | n/a | 57.6M | ||||||
| Low | n/a | 8.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.81 | -0.67 | |
| Avg | -1.32 | -0.65 | |
| Low | -2.25 | -0.63 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.